WS #10231

22:03→22:32 UTC

From 499 msgs · 3 key-dev

AbbVie said to be acquiring Apogee and its Dupixent rival for almost $11B, a sector-specific signal for biotech.

AbbVie-Apogee Acquisition Rumor

AbbVie said to be acquiring Apogee and its Dupixent rival for almost $11B, a sector-specific signal for biotech.